Press Release
Federal HEMP Crackdown & Cannabis Court Rulings Confirm MMJ's Pharmaceutical Vision
As Congress and the courts reaffirm federal supremacy in cannabis-hemp regulation, MMJ International Holdings stands with a DEA licensed lab, two accepted FDA Investigational new drug applications, and a completed THC-CBD soft gelatin medicine-proving that true compliance, not state loopholes, defines the future of cannabis medicine. Read More
Press Release
Kolter Homes Announces Grand Opening of Esprit at Avenir, Palm Beach Gardens' Newest Luxury 55+ Community
Experience Luxury Without Limits at Esprit at Avenir, where country club living, a full-service restaurant, and resort-style amenities redefine 55+ living in Palm Beach Gardens Read More
Press Release
Digital Landia Publishes Technical Whitepaper for AgenticPet AI Framework After One Year of Development and Stress Testing
Unlike Typical Tech Announcements, Whitepaper Documents Already Built and Validated Production System; Five Patent Pending Innovations Ahead of Q1 2026 Launch Read More
Press Release
CORRECTION: The Exterior Company Sweeps the 2025 Angi Super Service Awards Across Pennsylvania and Connecticut
This press release corrects and replaces the previous release distributed November 11, 2025 at 3:10 pm ET. The previous release contained an incorrect name in the quoted in the Central Pennsylvania: A Legacy of Trust section. The full corrected release follows. Read More
Press Release
Dolphin Clients Earn 35 Nominations for the 2026 GRAMMY Awards
Shore Fire Clients Alison Krauss & Union Station, Anoushka Shankar, Arturo O'Farrill & The Afro Latin Jazz Orchestra, Bon Iver, Margo Price, PJ Morton, Samara Joy, Tasha Cobbs Leonard, Tobias Jesso Jr. and 42West Client Andrew Watt All Receive Multiple Nominations Additional Nods Include Shore Fire Clients Bilal, Bruce Springsteen, Deborah Silver & The Count Basie Orchestra, Grace Potter, Jacob Collier, Joni Mitchell (Rhino Entertainment), Rhiannon Giddens, Samantha Fish, TajMo (Taj Mahal & Keb' Mo'), Terri Lyne Carrington and Trombone Shorty Read More
Press Release
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action. Read More
Press Release
Tectonic Metals Delivers Record 18,372 Metres Across 125 Drill Holes at Flat Gold Project, Alaska
Transformational $34M Capital Raise in 2025 Fuels Rapid and Aggressive Two-Phase Drill Campaign Positioning Flat for Growth Toward a Maiden Mineral Resource Estimate and Year-Round Operational Capacity Read More
Press Release
Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure
Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturers Integration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United States prescription drug market Read More
Press Release
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market. Read More
Press Release
CCL Industries Announces 2025 Third Quarter Results
Third Quarter Highlights Per Class B share(3): $1.21 adjusted basic earnings up 11.0%; $1.21 basic earnings up 12.0% Sales increased 6.3% on 3.7% organic growth, 0.1% acquisition growth and 2.5% positive currency translation Operating income(1) improved 11.4%, with a 16.4% operating margin(1) up 80 bps Returned $155.8 million to shareholders: $55.8 million in dividends and repurchased 1.3 million Class B shares for $100.0 million Nine-Month Highlights Per Class B share(3): $3.61 adjusted basic earnings up 9.4%; $3.60 basic earnings down 3.2%; 2024 included $0.44 revaluation gain in basic earnings Sales increased 6.5% on 3.1% organic growth, 0.8% acquisition growth and 2.6% positive currency translation Operating income(1) improved 9.9%, with a 16.6% operating margin(1) up 50 bps Returned $467.9 million to shareholders: $167.9 million in dividends and repurchased 3.9 million Class B shares for $300.0 million Read More
Press Release
ACCESS Newswire Reports Third Quarter 2025 Results
Increased ARR Leads to Higher Revenue and EBITDA Q3 2025 revenue grew modestly to $5.7M compared to $5.6M in Q2 2025 and Q3 2024 Q3 Adjusted EBITDA increased 71% to $933,000 compared to $546,000 in Q3 2024 Gross margin percentage remained strong at 75% Read More
Press Release
Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025
- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated Read More
Press Release
